Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioNexus Gene Lab Corp. BGLC

Full chart Compare
Set alert

Price alert · BGLC

All alert types
0.94 USD -0.01 (-1.05%)

Nov 4, 2026, 3:59 PM EST

0.91 Day range 0.94
0.883 52-week range 5.50
YTD
-76.20%
1 year
-82.30%

Financial health

Altman Z-Score

0.24 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 5

Valuation

P/E -2.5×
FY 2016: -2641000×FY 2017: -13271×FY 2018: 55021×FY 2019: -7722×FY 2020: 206×FY 2021: 482×FY 2022: -456×FY 2023: -3.5×FY 2024: -3.1×FY 2025: -2.5×
FY 2016 5y median -3.1× FY 2025
P/S 1.0×
FY 2016: 0.0×FY 2017: 1525×FY 2018: 688×FY 2019: 1497×FY 2020: 19.9×FY 2021: 27.3×FY 2022: 15.0×FY 2023: 0.9×FY 2024: 0.5×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
P/B 0.9×
FY 2016: -125280×FY 2017: 1736×FY 2018: 95.9×FY 2019: 169×FY 2020: 34.0×FY 2021: 50.8×FY 2022: 24.6×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
P/FCF -3.9×
FY 2016: -196698×FY 2017: 3874×FY 2018: -465×FY 2019: -826×FY 2020: 1728×FY 2021: 60816×FY 2022: 330×FY 2023: -4.8×FY 2024: -2.0×FY 2025: -3.9×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA -1.8×
FY 2016: 0.0×FY 2017: -1565×FY 2018: 1447×FY 2019: -851×FY 2020: 163×FY 2021: 312×FY 2022: -873×FY 2023: -1.3×FY 2024: -0.6×FY 2025: -1.8×
FY 2016 5y median -1.3× FY 2025
EV/Sales 0.7×
FY 2016: 0.0×FY 2017: 1517×FY 2018: 685×FY 2019: 1491×FY 2020: 19.7×FY 2021: 27.1×FY 2022: 14.8×FY 2023: 0.3×FY 2024: 0.1×FY 2025: 0.7×
FY 2016 5y median 0.7× FY 2025
FCF Yield -25.6%
FY 2016: -0.0%FY 2017: 0.0%FY 2018: -0.2%FY 2019: -0.1%FY 2020: 0.1%FY 2021: 0.0%FY 2022: 0.3%FY 2023: -20.9%FY 2024: -49.3%FY 2025: -25.6%
FY 2016 5y median -20.9% FY 2025

Profitability

Gross Margin 14.6%
FY 2016: 0.0%FY 2017: 73.2%FY 2018: 13.5%FY 2019: 44.0%FY 2020: 15.1%FY 2021: 16.4%FY 2022: 11.5%FY 2023: 13.6%FY 2024: 13.6%FY 2025: 14.6%
FY 2016 5y median 13.6% FY 2025
Operating Margin -42.5%
FY 2016: 0.0%FY 2017: -118.8%FY 2018: 28.2%FY 2019: -217.2%FY 2020: 11.2%FY 2021: 7.9%FY 2022: -2.7%FY 2023: -26.5%FY 2024: -16.5%FY 2025: -42.5%
FY 2016 5y median -16.5% FY 2025
Net Margin -40.2%
FY 2016: 0.0%FY 2017: -114.9%FY 2018: 12.5%FY 2019: -194.1%FY 2020: 9.6%FY 2021: 5.6%FY 2022: -3.3%FY 2023: -26.9%FY 2024: -16.8%FY 2025: -40.2%
FY 2016 5y median -16.8% FY 2025
ROE -34.6%
FY 2016: 63.7%FY 2017: -130.8%FY 2018: 1.7%FY 2019: -22.0%FY 2020: 16.4%FY 2021: 10.5%FY 2022: -5.3%FY 2023: -27.2%FY 2024: -19.2%FY 2025: -34.6%
FY 2016 5y median -19.2% FY 2025
ROIC -35.9%
FY 2016: 64.1%FY 2017: -128.9%FY 2018: 1.6%FY 2019: -20.3%FY 2020: 16.3%FY 2021: 10.4%FY 2022: -4.3%FY 2023: -26.4%FY 2024: -18.4%FY 2025: -35.9%
FY 2016 5y median -18.4% FY 2025
ROA -32.3%
FY 2016: -3211.5%FY 2017: -9.7%FY 2018: 1.6%FY 2019: -20.0%FY 2020: 10.8%FY 2021: 7.8%FY 2022: -4.1%FY 2023: -23.1%FY 2024: -15.3%FY 2025: -32.3%
FY 2016 5y median -15.3% FY 2025

Growth (YoY)

Revenue -21.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 97.2%FY 2019: -40.2%FY 2020: 8872.0%FY 2021: 17.3%FY 2022: -18.2%FY 2023: -10.6%FY 2024: -2.7%FY 2025: -21.9%
FY 2016 FY 2025
Operating Income -100.7%
FY 2016: 0.0%FY 2017: -15127.4%FY 2018: 146.8%FY 2019: -560.3%FY 2020: 562.0%FY 2021: -17.1%FY 2022: -127.6%FY 2023: -790.7%FY 2024: 39.3%FY 2025: -100.7%
FY 2016 FY 2025
EPS (diluted) -78.9%
FY 2016: 0.0%FY 2017: -19800.0%FY 2018: 124.1%FY 2019: -812.5%FY 2020: 3842.7%FY 2021: -58.6%FY 2022: -147.2%FY 2023: -512.0%FY 2024: 41.2%FY 2025: -78.9%
FY 2016 FY 2025
Free Cash Flow 23.8%
FY 2016: 0.0%FY 2017: 5177.2%FY 2018: -839.9%FY 2019: 26.7%FY 2020: 157.0%FY 2021: -95.4%FY 2022: 8195.6%FY 2023: -483.8%FY 2024: -28.8%FY 2025: 23.8%
FY 2016 FY 2025

Financial Health

Current Ratio 10.5×
FY 2016: 0.0×FY 2017: 0.9×FY 2018: 20.6×FY 2019: 17.1×FY 2020: 2.4×FY 2021: 3.0×FY 2022: 3.0×FY 2023: 4.9×FY 2024: 3.8×FY 2025: 10.5×
FY 2016 5y median 3.8× FY 2025
Quick Ratio 9.2×
FY 2016: 0.0×FY 2017: 0.8×FY 2018: 20.4×FY 2019: 17.0×FY 2020: 2.0×FY 2021: 2.4×FY 2022: 2.5×FY 2023: 4.2×FY 2024: 3.1×FY 2025: 9.2×
FY 2016 5y median 3.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2016: 0.0×FY 2017: 8.0×FY 2018: -5.7×FY 2019: 3.5×FY 2020: -1.9×FY 2021: -1.8×FY 2022: 11.1×FY 2023: 2.3×FY 2024: 2.9×FY 2025: 0.8×
FY 2016 5y median 2.3× FY 2025
Interest Coverage -162×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 113×FY 2021: 81.4×FY 2022: -23.3×FY 2023: -186×FY 2024: -74.4×FY 2025: -162×
FY 2016 5y median -74.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31